Market Herald logo

Subscribe

Be the first with the news that moves the market
Tilray Brands, Inc. | LinkedIn
Tilray Brands, Inc. | LinkedIn

Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical,
has received approval to commercialize its medical cannabis products in Poland.

The approval allows Tilray Medical to expand its product offering and distribution
across pharmacies in Europe.

Read the Full Story Here


Weekly Update – Top Cannabis News Stories

1 | Top Story: Pure Extracts (CSE:PULL) delivers its largest shipments to launch its newest vape product.

2 | Innocan Pharma (CSE:INNO) reports positive results in pilot pain study using LPT CBD Liposomal Delivery Platform.

3 | Juva Life (CSE:JUVA) launches revised JuLi registry, showcases cannabis and CBD brands

4 | Delta 9 (TSX:DN) to acquire three retail cannabis stores in an all-share transaction.

5 | EnwWave Corp. (TSXV:ENW) signs technology evaluation agreement with Canadian cannabis cultivator

Top Cannabis Stocks August 11 to August 17, 2022

1. T.WEED | 12,762 views | Canopy Growth Corp.
2. T.HEXO |11,577 views | HEXO Corp.
3. TLRY | 8,407 views | Tilray Brands Inc.
4. C.TNY | 4,812 views | Aleafia Health Inc.
5. T.AH | 4,542 views | Tinley Beverage Co Inc.
6. C.TBP | 2,984 views | Tetra BioPharma Inc.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.


More From The Market Herald

" Silvercorp Metals Inc. Confirms Its Golden Potential with a Reserve and Resource Update

By Dr. Ryan D. Long

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.
Isracann Biosciences Inc. - CEO, Phil Floucault

" Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.